CTY stock news today

Form 4 reports shares bought or sold by company insiders such as officers, directors or large holders.

Form 8-K tells shareholders about important events such as deals, leadership changes or results.

This is a public filing with the U.S. Securities and Exchange Commission.

City Therapeutics sets IPO price at $18.00 per share, 11,111,111 shares total

City Therapeutics priced its enlarged initial public offering at $18.00 per share. The company is offering 11,111,111 shares, which would bring in roughly $200 million before expenses.

What is the latest news on CTY?

Oct 19, 2026: City Therapeutics, Inc. filed an insider trading report (Form 4) (SEC) · Oct 19, 2026: City Therapeutics, Inc. filed a report on a major company event (Form 8-K) (SEC) · Oct 15, 2026: City Therapeutics, Inc. filed Form S-1MEF with the SEC (SEC)

What has CTY filed with the SEC recently?

Oct 19, 2026: City Therapeutics, Inc. filed an insider trading report (Form 4) · Oct 19, 2026: City Therapeutics, Inc. filed a report on a major company event (Form 8-K) · Oct 15, 2026: City Therapeutics, Inc. filed Form S-1MEF with the SEC